Back to search

National and Kapodistrian University of Athens

Ο ρόλος των βιοδεικτών στο οξύ αγγειακό εγκεφαλικό επεισόδιο

Abstract

dc:description

Introduction: A stroke refers to a focal or generalized disorder of cerebral function that lasts more than 24 hours and is exclusively due to vascular causes. Two pathological types are distinguished according to aetiology: ischemic stroke (IS), which accounts for 80% of strokes, and hemorrhagic stroke (HS), which accounts for 20% of strokes. The most important milestones in the management of stroke are the differential diagnosis between ischemia, hemorrhage and stroke mimics (SM), the application of reperfusion therapies in the acute phase in the case of IS and the prompt management of HS, prognosis and therapeutic strategies for secondary prevention. However, the means available to achieve the goals are not available in all geographic areas and/or 24/7. The necessity of timely and correct diagnosis is therefore recognized in order to apply the appropriate management and treatment protocols in each case. An alternative approach to the differential diagnosis and prognosis of acute stroke can be achieved through variable blood substances, so-called "biomarkers", which appear to be able to reflect the body's response to the damage caused by the different types of stroke in measurements at different time points. Specific biomarkers should differentiate IS from HS and SM, identify large-vessel occlusion, predict the time of onset of stroke, and provide evidence for its progression and prognosis. In this way, in places where the technological means are not available, but also in those where they are, the diagnosis will be accelerated, the appropriateness of reperfusion treatments will be increased and aggressive treatments will be started immediately, such as arterial pressure regulation in intracerebral hemorrhage (ICH). Overall, it will enable the treatment of a larger part of the population, achieving optimal management of stroke in the acute phase. The main purpose of the present PhD thesis was to investigate the change in the levels of biomarkers in the acute and subacute phase of stroke and to correlate it with the differential diagnosis between IS, ICH and SM, with the risk factors of stroke and prognosis. In addition, through two systematic reviews, we wanted to show the importance of this approach of stroke which, compared to others, is easier, more economical and can be carried out everywhere, thus emphasizing the necessity of its implementation. Methods: We performed a systematic review of the literature aiming to demonstrate the inflammatory mechanisms involved in the pathophysiology of stroke, as well as the role of CRP in the acute phase of IS and HS. Then we evaluated patients with acute IS who were hospitalized in the 2nd Neurological Clinic of the NKUA at the University General Hospital "Attikon" during 3 years (February 2013 - January 2016). We wanted to show the association of CRP levels with the severity of IS and its role as a prognostic factor for IS. We studied the role of glial fibrillary acidic protein (GFAP) in the differential diagnosis of ICH. We then evaluated patients presenting to a tertiary care hospital's emergency department (KAT) during a 3-year period (January 2013–December 2015), and excluded patients with symptoms >6 hours or previous stroke, traumatic brain injury or brain tumor. We wanted to assess prospectively the diagnostic accuracy of GFAP in the differential diagnosis of ICH from IS and other acute neurological disorders. We studied the levels of vaspin and omentin during the early phase of IS in patients with symptom duration less than 24 hours who came to the Emergency Department of the 2nd Neurological Clinic of the NKUA at the University General Hospital "Attikon" for two years (January 2018 – December 2019). We sought to investigate possible associations of omentin and vaspin levels with clinical and neuroimaging characteristics. We performed a systematic review of biomarkers studied in IS. We sought to show their role in the acute phase and the limitations that apply so far making it impossible to use them as diagnostic, prognostic and differentiation tools between different conditions. Results: In the acute phase but also during the course of IS and HS, intense inflammatory reactions take place which are characterized by similar pathogenetic mechanisms, however presenting significant differences between them. Acute phase proteins have an initial and leading role, among them C-reactive protein (CRP). From the studies so far, a clear association of the risk for IS has been seen with the finding of high levels of CRP concentration, while its significance in HS has not yet been established. A total of 186 patients with acute IS (66% male, mean age 57±12 years) with available routine CRP measurement during the first 48 hours of their hospitalization were evaluated. Elevated CRP was found in 68 patients (36%; 95%CI: 29%-43%) and was more frequent in moderate to severe stroke (27% vs 8%; p=0.001). Among patients with elevated CRP, baseline stroke severity was positively associated with CRP levels (r:+0.352; p=0.004). Elevated CRP was independently associated with a higher probability of risk for manifestation of moderate or severe IS in multivariable logistic regression models after statistical adjustment for demographics, CPA subgroups, and vascular risk factors (OR: 4.53, 95% CI: 1.10-18.66; p=0.037).We studied 270 patients with a discharge diagnosis: IS (n=121), ICH (n=34), SM (n=31) and SAH (n=5) as well as controls (n=79). SM, controls and SAH patients were younger compared to the rest of the population. No differences were found in baseline stroke severity and time from onset to sample collection between patients with IS, ICH and SAH. Patients with ICH had a higher mean concentration of GFAP values ng/ml (2.17; interquartile range [IQR], 0.55-10.12) compared with IS (0.11; IQR, 0-0.27), MS (0.07; IQR, 0.07) -024), controls (0;IQR, 0-0.21) and SAH (0;IQR, 0-0.22;). Our study showed that serum GFAP is a sensitive and specific biomarker for the differential diagnosis of ICH from IS, SM, SAH and controls, with optimal diagnostic performance at the second hour of symptom onset. Our results are congruent with previous studies, however, the threshold of 0.43ng/ml we used, confers the highest diagnostic accuracy for the differentiation between ICH and IS reported to date, with higher sensitivity values and no significant loss of specificity. We studied 135 consecutive patients with IS who presented within 24 of symptom onset: 105 (78%) IS and 30 (22%) TIA. Median age of patients was 59+/- 10 years, 92 (68%) were male, and median NIHSS at admission was 3 points (IQR:1-7). Multiple linear regression revealed that increasing levels of omentin were independently associated with increasing age (LCR=0.170, 95%CI:0.063-0.277; P =0.0023), greater admission NHISS (LCR=0.290, 95%CI:0.063- 0.51; P = 0.013) and ipsilateral carotid artery stenosis (LCR=3.411, 95%CI: 0.194-6.628; P=0.038). Omentin also appeared to be closely related to increasing age (Spearman rho coefficient:+0.303; p<0.001) and stroke severity at admission (Spearman rho coefficient:+0.351; p<0.001). We also estimated omentin levels in patients with acute IS categorized according to the presence of ipsilateral carotid artery stenosis (>50% NASCET criteria). Significantly higher omentin levels were found in patients with ipsilateral carotid artery stenosis compared to patients without carotid disease (13.3+/-8.9ng/ml vs 9.5+/-5.5ng/ml, p=0.014). For vaspin concentrations, simple linear regression did not reveal a significant association with clinical characteristics, diagnostic results, or outcome of patients with IS, and therefore no further analysis was performed. We made a brief description of IS and its subtypes in the different categories: atherothrombotic, cardioembolic, small vessel disease and cryptogenic and analyzed in detail different mechanisms involving acute phase mechanisms. We demonstrated molecules and mechanisms that are potential targets for differential diagnosis, prognosis and treatment of IS. Then we analyzed the role of biomarkers, how they were selected, their use so far and the methods by which they are analyzed and measured. Finally, we listed the limitations and difficulties encountered in order to establish and use them in daily clinical practice, and proposed solutions. Conclusions: As shown in the three studies and two reviews, the inflammatory processes occurring in both IS and HS have an important role in the development, exacerbation, prognosis and outcome of stroke as well as in differentiating IS from HS and SM. Therefore, studying the levels of biomarkers involved in these processes and incorporating them as part of the processes is absolutely essential. If we take for example the use of troponin, the measurement of which has been established worldwide and reflects myocardial ischemic damage in case of elevation, we can understand the necessity of similar biomarkers for stroke. However, their use should not be limited only to the parameters of the acute phase. According to the processes described in the stages of inflammation, they could also be used as treatment targets in both acute and chronic phases, thus also covering secondary prevention. In conclusion, the scientific community should invest in such new approach targets of stroke as the benefit from their use may exceed expectations.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chondrogianni, Maria
  • Χονδρογιάννη, Μαρία

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55845

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chondrogianni, Maria; Χονδρογιάννη, Μαρία. Ο ρόλος των βιοδεικτών στο οξύ αγγειακό εγκεφαλικό επεισόδιο. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/55845